Bill Gates, co-chair of the Bill & Melinda Gates Foundation and co-founder of the Microsoft Corporation, announced that he is investing $100 million toward Alzheimer’s disease research. Half of that will go to the Dementia Discovery Fund, a venture capital effort that includes philanthropic, government and pharmaceutical partners.
Gates says that he is hoping to fund innovative ideas for treatments that aren’t currently being tested by the pharmaceutical industry. “From a societal point of view, we need huge risk-taking on this one,” he tells Time.
Recent trials of promising drugs have been disappointing. Drugs aimed at dissolving amyloid plaques that can build up in the brain and strangle neurons have failed to reduce or delay symptoms in people with mild to moderate forms of Alzheimer’s disease. Read more